HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • RECORDED WEBINAR: AI for Care Management: How ACOs Can Extend Care Teams Without Adding Headcount
  • RECORDED WEBINAR: Humanizing Health Tech in the Age of AI
  • The V28 Mid-Year Checkpoint: What Your Risk Adjustment Team Should Be Measuring Right Now
  • Positive ‘Spillover Effects’: Nursing Homes Should Hitch Themselves to ACOs as CMS Expands Program
  • Wellness or waste? How extra visits can undermine shared savings for ACOs
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us